Treatment of gastro-oesophageal reflux disease through control of transient lower oesophageal sphincter relaxations--feasibility, practicality and possibilities.
Holloway
R H
RH
D000818:Animals; D018680:Cholinergic Antagonists / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D004943:Esophagogastric Junction / Q000294:innervation / Q000503:physiopathology*; D005240:Feasibility Studies; D018756:GABA Antagonists / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008365:Manometry; D010276:Parasympatholytics / Q000627:therapeutic use*; D011312:Pressure; D014630:Vagus Nerve / Q000187:drug effects / Q000503:physiopathology*
D018680:Cholinergic Antagonists; D004791:Enzyme Inhibitors; D018756:GABA Antagonists; D010276:Parasympatholytics